Mylan launches generic Estradiol Vaginal Cream after securing FDA approval
Mylan, a global pharmaceutical company, has recently announced the U.S. Food and Drug Administration (FDA) approval of its Estradiol Vaginal Cream USP, 0.01%, a generic version of Allergan’s Estrace. This approval marks a significant addition to Mylan’s comprehensive women’s healthcare offerings, particularly targeting the treatment of vulvar and vaginal atrophy, a condition prevalent among postmenopausal […]